Furthermore, irreversible Piezo2 channelopathy-induced loss of Piezo2–Piezo1 crosstalk is proposed to increase insulin resistance and dysregulate glucose metabolism in ALS [18]. The gene discussed is PIEZO2; the disease is channelopathy.